San Diego-based Illumina, a developer of gene sequencing tools, said today that it has named Elizabeth Brady as the firm's Vice President, Global Supply Chain, and Emily S. Winn-Deen, Ph.D., as its Vice President, Diagnostics Development. Brady joins from Boston Scientific Corporation, and has also served at Tellabs Operations and 3Com. Winn-Deen joins from Rx Dx Advisors, and also has served at Cepheid, Roche Molecular Systems, Applera Corporation, Oncor, and Bayer Diagnostics.